» Articles » PMID: 38906739

Conservative Surgical Treatment for Adenomyosis: New Options for Looking Beyond Uterus Removal

Overview
Publisher Elsevier
Date 2024 Jun 21
PMID 38906739
Authors
Affiliations
Soon will be listed here.
Abstract

Adenomyosis is a common benign uterine disorders and patients may present dysmenorrhea, dyspareunia, abnormal uterine bleeding (AUB) and infertility. The treatment is very complex, including medical, surgical or radiological approaches. Hormonal drugs represent the first line therapy of adenomyosis, highly effective on symptoms and uterine volume reduction. Radiological procedures (UAE and HIFU), RFA and hysteroscopy may be proposed in those cases in which medical therapy is ineffective. Considering surgical treatment, hysterectomy remains the only existing definitive treatment but in the last decades the desire of uterus preservation is becoming more and more diffuse. On the other hand, surgical conservative treatments of adenomyosis are very effective in ameliorating AUB and pelvic pain and in reducing uterine volume, with some post-operative risks and obstetrics complications. Cytoreductive surgery for adenomyosis may be very complex, therefore it should be performed by experienced surgeons in dedicated centers, above all in case of concomitant endometriosis.

Citing Articles

Case Report: The first case of successful pregnancy and live birth following laparoscopic resection of adenomyosis under real-time intraoperative ultrasound elastography guidance.

Ota Y, Ota K, Takahashi T, Horikawa N, Kuroda R, Okamoto H Front Med (Lausanne). 2024; 11:1457611.

PMID: 39391043 PMC: 11464352. DOI: 10.3389/fmed.2024.1457611.


The Current Understanding of Molecular Mechanisms in Adenomyosis-Associated Infertility and the Treatment Strategy for Assisted Reproductive Technology.

Wu H, Tsai T, Liu S, Pai A, Chen L Int J Mol Sci. 2024; 25(16).

PMID: 39201621 PMC: 11354813. DOI: 10.3390/ijms25168937.